The Infinium Global Research analyzes the report of Implantable Drug Delivery Devices Market over the period of 2018 to 2024. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Implantable Drug Delivery Devices Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global markets of Implantable Drug Delivery Devices.
The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the Implantable Drug Delivery Devices Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Implantable Drug Delivery Devices Market are Allergan, Boston Scientific Corporation, Bayer AG, Alimera Sciences, Eyepoint Pharmaceuticals, Mecrk & Co., Inc, Abbott, Valeant Pharmaceuticals and Medtronic. According to report the global Implantable drug delivery devices market is projected to grow at a CAGR of 6.22% over the forecast period of 2018-2024.
The global implantable drug delivery devices market is set to experience substantial growth over the forecast period. Primarily driven by increasing population, rise in number of cancer cases, growing number of cardiology, ophthalmology abnormalities, trend of contraception and technological advancements. On the other hand, the risk of infection, risk of overdose/under-dose due to technical difficulty of the devices, high cost will likely to restrain the growth of the market. Merger and acquisition activities among leading service providers will enlighten the opportunities for the same market for the growth over the forecast period. The global implantable drug delivery devices market was worth USD 13,499.43 million in 2017 and it is projected to reach USD 20,589.07 million in 2024, expanding at a CAGR of 6.22% between 2018 and 2024.
According to the World Health Organization (WHO), around 30% of the deaths occurred from cardiovascular disease (particularly from coronary heart disease) across worldwide and the number of cases has been rapidly growing. In addition, the worldwide prevalence of glaucoma varies from 2% to 6%, (found highest in the South Africa). In South Korea, prevalence of glaucoma has been increased 54% between 2008 and 2013.
Furthermore, the rising number of cancer cases is another factor that propels the growth of the implantable drug delivery devices market. According to GLOBOCAN, the incidence of cervical cancer is significantly high in North America region as compared to Asia-Pacific region. But high diagnosis and treatment rate of cervical cancer in North America region lower the rate of growth of cervical cancer cases in North America. On the other hand, low cervical cancer screening rate in Asia-Pacific region leads to rapid increment of cases of cervical cancer in Asia-Pacific region.
Rising number of coronary heart diseases, glaucoma, cancer cases across worldwide will primarily drive the demand of the global implantable drug delivery devices market.
The report on global Implantable drug delivery devices market covers segments such as, product type, technology and applications. On the basis of product type the global Implantable drug delivery devices market is categorized into coronary drug eluting stent, bio-absorbable stent, implantable contraceptive devices, implantable intraocular devices, drug infusion pumps and brachytherapy seeds. On the basis of technology the global Implantable drug delivery devices market is categorized into bio-degradable, non-biodegradable and smart pills. On the basis of applications the global Implantable drug delivery devices market is categorized into ophthalmology, cardiology, contraceptive, oncology and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, Latin America and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2016-2024.
North America accounted for the largest market share in the global market in 2016 and 2017. In 2017, the market size of North America implantable drug delivery devices market was USD 4,993.61 million and it is anticipated to reach to USD 7,589.13 million in 2024. The growth in the region is mainly driven by increasing number of cardiology, ophthalmology, abnormalities, growing number of cancer cases in North America region. Asia-Pacific is expected to growth at the highest CAGR of 6.57% over the forecast period. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global Implantable drug delivery devices market such as, Allergan, Boston Scientific Corporation, Bayer AG, Alimera Sciences, Eyepoint Pharmaceuticals, Mecrk & Co., Inc, Abbott, Valeant Pharmaceuticals and Medtronic.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global Implantable drug delivery devices market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of Implantable drug delivery devices market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the Implantable drug delivery devices market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the Implantable drug delivery devices market to understand the present and future trends in this market and formulate their strategies accordingly.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-implantable-drug-delivery-devices-market